Tricida Profile

Performance

Odds of Distress

25%25%
Analyze Filter    Check how we calculate scores
Equity ratings for Tricida are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting September 8, 2019 and ending today December 7, 2019. Click here to learn more.

Tricida Profile

Tricida, Inc., a pharmaceutical company, focuses on the development and commercialization of its drug candidate, TRC101, a non-absorbed, orally-administered polymer designed as a potential treatment for metabolic acidosis in patients with chronic kidney disease . Tricida, Inc. was founded in 2013 and is headquartered in South San Francisco, California. Tricida operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 104 people. more
NameTricida
CEOGerrit KlaernerView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address7000 Shoreline Court
ExchangeBATS Exchange
SectorHealthcare
IndustryDrug Manufacturers?Specialty & Generic
BenchmarkDOW
Websitewww.tricida.com
Phone415 429 7800
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterSeptember 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestNovember 15, 2019
Tricida (TCDA) is traded on BATS Exchange in USA and employs 104 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.98 B. Tricida conducts business under Healthcare sector and is part of Drug Manufacturers?Specialty & Generic industry. The entity has 49.61 M outstanding shares of which 3.51 M shares are at this time shorted by private and institutional investors with about 13.17 trading days to cover. The company currently holds about 322.23 M in cash with (132.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.49.
Check Tricida Probability Of Bankruptcy

Ownership Allocation (%)

Tricida Target Price Odds Analysis

Odds Below 39.69HorizonTargetOdds Above 39.69
74.78%30 days 39.69 25.08%
Based on normal probability distribution, the odds of Tricida to move above current price in 30 days from now is about 25.08 (This Tricida probability density function shows the probability of Tricida Stock to fall within a particular range of prices over 30 days) .

Tricida Top Holders

Tricida Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Orbimed Advisors LlcCommon Shares11.1 M343.1 M
Price T Rowe Associates IncCommon Shares4.1 M127.5 M
View Tricida Diagnostics

Tricida Risk Profiles

Tricida Key Fundamentals

Tricida Against Markets

Did you try this?

Run Global Markets Map Now

   

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Module

Tricida Corporate Directors

Robert Alpern Independent Director
David Hirsch Independent Director
Sandra Coufal Independent Director
Also please take a look at World Market Map. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.
Search macroaxis.com